Surprise Pfizer announcement weighs on stocks
444667
Pfizer&#39;s surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading Friday, renewing investors&#39; concerns over the pharmaceutical sector.
568209
U.S. stocks looked set to open slightly higher on Monday as a spate of acquisition deals suggested optimism about the economy, but Pfizer Inc.'s  decision to abandon a key experimental drug hammered its shares.
768203
NEW YORK - Stocks were mixed Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
132494
US stocks fell as setbacks for drugmakers, including a study showing Pfizer Inc.&#39;s Celebrex painkiller increased the risk of heart attacks, sent health-care shares tumbling.
108463
Pfizer is a good company, but a bad stock for 2008.
376612
US STOCKS were knocked lower yesterday as investors worried that rising prices for oil and commodities would dent corporate profits, while drug shares fell on possible stricter scrutiny from regulators.
438859
NEW YORK (CBS.MW) - US stocks traded mixed Thurday as Merck shares lost a quarter of their value, dragging blue chips lower, but the Nasdaq moved higher, buoyed by gains in the semiconductor sector.
488041
Foreign drug stocks were in the spotlight Thursday with Food and Drug Administration news pulling the sector down. AstraZeneca PLC took a drubbing on the eve of its FDA advisory panel meeting for its orally
718301
Pfizer Inc , the world's  biggest drug maker, on Wednesday reported fourth-quarter  results that beat expectations, sending its shares higher in  premarket trading.
591006
Stocks fell on Wednesday after bank  JPMorgan Chase & Co.JPM.N and drug maker Pfizer Inc. PFE.N  reported disappointing earnings, while a lackluster outlook  from cell-phone maker Motorola Inc. MOT.N stoked concerns  about weak technology spending.
387898
Pfizer Inc, Novartis AG and Wyeth all  saw quarterly earnings hit by charges on Thursday, while Eli  Lilly and Co exceeded Wall Street expectations as third-quarter  sales of several of its drugs outpaced analysts' estimates.
93547
U.S. stocks gained strength on  Tuesday, getting a boost from Pfizer Inc. PFE.N, after  investor fears of the withdrawal of its arthritis drug Celebrex  were calmed, while IAC/InterActive Corp.'s IACI.O helped fuel  the tech-heavy Nasdaq.
311418
Investors in pharmaceuticals were dealt  a triple whammy on Friday as Pfizer Inc, AstraZeneca Plc and  Eli Lilly and Co all shocked the market with bad news about key  products.
244370
U.S. stocks fell on Friday dragged  down by a string of negative reports from drug makers, with  Pfizer Inc. PFE.N, AstraZeneca Plc. AZN.L and Eli Lilly and  Co. LLY.N delivering bad news about key products.
489823
Shares in Pfizer Inc, the world's biggest drugmaker, fell more than 10 percent in early trade in Europe on Monday, after news it had scrapped its most important experimental drug.
443779
Investors in pharmaceuticals were dealt a triple whammy on Friday as Pfizer Inc, AstraZeneca Plc and Eli Lilly and Co all shocked the market with bad news about key products.
383002
Pfizer Inc.  on Monday boosted its quarterly dividend 21 percent after the surprise failure of its most important experimental drug caused a sell- off in its shares, and gave its new chief executive additional duties as chairman.